Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study
Adrian Duek, Alexandra Tzinman, Kira Maziuk, Assaf Levy, Martin Ellis, Galia Stemer, Adi Shacham Abulafia, Amos Cohen, Noa Lavi, Aaron Ronson, Andrey Braester, Shirley Shapira, Jonathan Canaani, Yulia Volchek, Ronit Leiba, Merab Leiba
Research output: Contribution to journal › Article › peer-review
1Scopus
citations
Fingerprint
Dive into the research topics of 'Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study'. Together they form a unique fingerprint.